April 1, 2009 (Nashville, Tennessee) — Lanthanum carbonate reduced mortality in patients with stage?5 chronic kidney disease (CKD) and had no negative effect on vitamin?D levels in patients with stage?3 or 4 CKD, according to studies presented here at the National Kidney Foundation 2009 Spring Clinical Meetings.
Prospective-outcomes studies of lanthanum carbonate in stage?5 CKD patients have not yet been conducted, but investigators performed a post hoc analysis of an earlier safety study under guidance from regulatory authorities.
Read the rest of this entry…
